Startup Profile: Lactiga (020)

Episode 20 September 05, 2021 00:48:50
Startup Profile: Lactiga (020)
Innovation4Alpha
Startup Profile: Lactiga (020)

Sep 05 2021 | 00:48:50

/

Show Notes

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. They are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including Covid. Lactiga has earned multiple awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.

AngelMD Profile: https://www.angelmd.co/en/startups/lactiga

Other Episodes

Episode 17

May 24, 2022 00:19:03
Episode Cover

DelNova: Addressing complications from Botox (217)

DelNova, Inc. is a biopharmaceutical company focused on addressing unmet medical needs. DelNova is resolving complications arising from botulinum toxin therapies (eg. Botox®). The...

Listen

Episode 15

May 21, 2022 00:28:00
Episode Cover

CadexGenomics: Taking the Fight to Stage 4 Cancer (215)

The Cadex Genomics mission and passion is to improve the lives of cancer patients. They have developed a novel, blood-based assays for patients with...

Listen

Episode 3

July 21, 2023 00:28:09
Episode Cover

Pathkeeper: Next Generation Surgical Robot

PathKeeper is an innovative robotic company founded in Israel.The company's disruptive, proprietary technology provides laser-like accuracy for spinal procedures. The unique technology tracks the...

Listen